| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0378 |
Hospital observation service, per hour |
3,855 |
3,276 |
$1.15M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
7,062 |
6,442 |
$784K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,763 |
5,281 |
$537K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
5,095 |
3,324 |
$311K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,511 |
3,114 |
$250K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
362 |
253 |
$35K |
| 90791 |
Psychiatric diagnostic evaluation |
98 |
93 |
$20K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
344 |
309 |
$14K |
| 86850 |
|
328 |
293 |
$9K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,889 |
2,512 |
$8K |
| 80053 |
Comprehensive metabolic panel |
12,598 |
10,220 |
$7K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,018 |
2,925 |
$6K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
51 |
43 |
$5K |
| 71046 |
Radiologic examination, chest; 2 views |
2,991 |
2,811 |
$4K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
722 |
690 |
$4K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
187 |
147 |
$4K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,002 |
6,209 |
$3K |
| 11043 |
|
19 |
13 |
$2K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
190 |
184 |
$2K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,094 |
2,918 |
$2K |
| 84484 |
|
6,452 |
4,690 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
3,059 |
2,879 |
$2K |
| 85027 |
|
9,970 |
6,895 |
$2K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
510 |
484 |
$1K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,319 |
5,458 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
119 |
95 |
$956.82 |
| 87088 |
|
1,867 |
1,715 |
$757.81 |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
137 |
133 |
$738.21 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
661 |
633 |
$726.41 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,433 |
1,314 |
$719.42 |
| 81001 |
|
6,790 |
6,067 |
$656.02 |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
68 |
64 |
$523.65 |
| 87040 |
|
458 |
437 |
$441.98 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
500 |
350 |
$369.66 |
| 83605 |
|
2,947 |
2,550 |
$340.80 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,662 |
1,197 |
$310.93 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
271 |
211 |
$242.07 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,647 |
1,017 |
$239.73 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,285 |
1,851 |
$222.80 |
| 83880 |
|
1,279 |
1,140 |
$194.47 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
555 |
497 |
$163.63 |
| 93971 |
|
57 |
56 |
$159.20 |
| 84703 |
|
905 |
785 |
$146.83 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
408 |
395 |
$122.29 |
| 83690 |
|
2,448 |
2,200 |
$119.50 |
| 85610 |
|
2,123 |
1,680 |
$114.08 |
| 87186 |
|
389 |
368 |
$100.07 |
| 83735 |
|
4,162 |
3,451 |
$88.22 |
| 85730 |
|
285 |
271 |
$68.84 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
165 |
158 |
$68.16 |
| E1352 |
Oxygen accessory, flow regulator capable of positive inspiratory pressure |
27 |
25 |
$61.58 |
| 85379 |
|
182 |
176 |
$56.42 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
56 |
53 |
$56.23 |
| 87077 |
|
197 |
186 |
$47.91 |
| 80320 |
|
484 |
441 |
$36.70 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
89 |
69 |
$36.21 |
| 82248 |
|
145 |
125 |
$34.05 |
| 71250 |
|
14 |
14 |
$26.32 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
920 |
749 |
$24.48 |
| A4663 |
Blood pressure cuff only |
47 |
38 |
$18.00 |
| J2704 |
Injection, propofol, 10 mg |
191 |
158 |
$11.03 |
| 81025 |
|
117 |
107 |
$10.54 |
| J2060 |
Injection, lorazepam, 2 mg |
270 |
216 |
$4.37 |
| 86901 |
|
358 |
325 |
$4.17 |
| 86900 |
|
358 |
325 |
$4.12 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
176 |
147 |
$3.98 |
| 82150 |
|
282 |
263 |
$2.13 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
113 |
109 |
$1.06 |
| A6196 |
Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing |
60 |
33 |
$0.00 |
| 94799 |
|
276 |
213 |
$0.00 |
| 87899 |
|
59 |
59 |
$0.00 |
| 94664 |
|
41 |
38 |
$0.00 |
| 80164 |
|
66 |
54 |
$0.00 |
| 84450 |
|
88 |
85 |
$0.00 |
| 84702 |
|
31 |
25 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
98 |
89 |
$0.00 |
| 84100 |
|
50 |
34 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
126 |
61 |
$0.00 |
| 80061 |
Lipid panel |
14 |
13 |
$0.00 |
| 84588 |
|
34 |
30 |
$0.00 |
| 97161 |
|
15 |
15 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
32 |
25 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
973 |
857 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
49 |
49 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
251 |
237 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
85 |
85 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
172 |
138 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
143 |
137 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
63 |
52 |
$0.00 |
| 84132 |
|
179 |
174 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
39 |
38 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
26 |
12 |
$0.00 |
| 97165 |
|
14 |
14 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
13 |
12 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
14 |
14 |
$0.00 |